STAAR Surgical (NASDAQ:STAA) & Alpha Tau Medical (NASDAQ:DRTSW) Financial Contrast

Alpha Tau Medical (NASDAQ:DRTSW) and STAAR Surgical (NASDAQ:STAA) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Earnings & Valuation

This table compares Alpha Tau Medical and STAAR Surgical”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Tau Medical	N/A	N/A	N/A	N/A	N/A
STAAR Surgical	$239.44 million	4.85	-$80.45 million	$0.07	330.57

Alpha Tau Medical has higher earnings, but lower revenue than STAAR Surgical.

Analyst Ratings

This is a summary of current ratings for Alpha Tau Medical and STAAR Surgical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Tau Medical	0	0	0	0	0.00
STAAR Surgical	3	7	2	1	2.08

STAAR Surgical has a consensus price target of $28.40, indicating a potential upside of 22.73%. Given STAAR Surgical’s stronger consensus rating and higher probable upside, analysts plainly believe STAAR Surgical is more favorable than Alpha Tau Medical.

Institutional & Insider Ownership

96.7% of STAAR Surgical shares are owned by institutional investors. 39.9% of STAAR Surgical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Alpha Tau Medical and STAAR Surgical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Alpha Tau Medical	N/A	N/A	N/A
STAAR Surgical	1.13%	9.05%	6.99%

Summary

STAAR Surgical beats Alpha Tau Medical on 10 of the 10 factors compared between the two stocks.

About Alpha Tau Medical

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.